Global Cardiomyopathy Market Research and Forecast 2018-2023

  • ID: 4585990
  • Report
  • Region: Global
  • Orion Market Research Private Limited
1 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Becton And Dickson & Co.
  • Bio-Rad Laboratories
  • Covance
  • Glaxosmithkline Plc
  • Merck & Co., Inc.
  • MORE
Cardiomyopathy is a disease of the heart muscle. It affects any age group and is a serious lifelong condition. The major factors that contributes in the growth of the market are advancement in understanding and managing cardiomyopathy and rise in incidences of congestive heart failure, coronary heart disease, and heart attack. Further, increasing trend of minimally invasive technology and availability of remote monitoring solutions are estimated to contribute in the growth of the market. However, high cost of diagnosis & treatment and lack of public awareness are considered to be the major restraining factors in the growth of the market. Increasing medical tourism in emerging countries and increasing research and development for the cardiomyopathy treatment are developing numerous opportunities for the growth of the cardiomyopathy market.

The major types of cardiomyopathy include dilated cardiomyopathy, hypertrophic cardiomyopathy and restrictive cardiomyopathy. These types of cardiomyopathy can be inherited. Further, it can be caused by viral infection in heart or heart attack. Dilated cardiomyopathy occurs when the muscles of heart begin to stretch and become thinner. Hypertrophic cardiomyopathy happens when the muscles of heart cells enlarge and cause the walls of the heart to thicken. Restrictive cardiomyopathy tends to affect older adults. The heart becomes rigid as the abnormal tissue replaces the normal heart muscle, so the heart muscle is unable to relax.

On the basis of the geography, the global cardiomyopathy market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America is estimated to account for major share in the global cardiomyopathy market owing to increasing incidence of heart diseases such as coronary heart disease or heart attack in this region. Asia Pacific is estimated to be the fastest growing region during the forecast period owing to increasing medical tourism in emerging countries such as India and China. Key players of the cardiomyopathy market are Array Biopharma, Inc., Boston Scientific Corporation, Cisbio Bioassays, Covance, Critical Diagnostics, Mylan N.V, Pfizer, Inc., Becton and Dickson & Co., BG Medicine Inc., Biomerieux and Bio-Rad Laboratories.

Research Methodology:

The market study of global cardiomyopathy market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Whitepapers such as research-papers and news blogs
  • Company websites and their product catalogue.
The Report is intended for Researchers in healthcare segment, medical companies in the market, Investing companies, Government Organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in market, product types. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

The Report Covers
  • Comprehensive research methodology of global cardiomyopathy market
  • In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global cardiomyopathy market
  • Insights about market determinants which are stimulating the global cardiomyopathy market
  • Detailed and extensive market segments with regional distribution of forecasted revenues
  • Extensive profiles and recent developments of market players
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Becton And Dickson & Co.
  • Bio-Rad Laboratories
  • Covance
  • Glaxosmithkline Plc
  • Merck & Co., Inc.
  • MORE
Chapter 1. Report Summary
1.1. Research Methods And Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

Chapter 2. Market Overview And Insights
2.1. Definition
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1.1. United States
2.3.1.2. European Union
2.3.1.3. China
2.3.1.4. India

Chapter 3. Market Determinant
3.1. Motivators
3.1.1. Advancement In Understanding And Managing Cardiomyopathy
3.1.2. Rise In Incidences Of Congestive Heart Failure, Coronary Heart Disease, And Heart Attack
3.1.3. Increasing Trend Of Minimally Invasive Technology
3.1.4. Availability Of Remote Monitoring Solutions
3.2. Restraints
3.2.1. High Cost Of Diagnosis And Treatment
3.2.2. Lack Of Public Awareness
3.3. Opportunities
3.3.1. Increasing Medical Tourism In Emerging Countries
3.3.2. R&D Exploration Is On Rise

Chapter 4. Market Segmentation
4.1. Global Cardiomyopathy Market, By Type
4.1.1. Dilated Cardiomyopathy
4.1.2. Hypertrophic Cardiomyopathy
4.1.3. Restrictive Cardiomyopathy
4.1.4. Arrhythmogenic Right Ventricular Dysplasia
4.1.5. Unclassified Cardiomyopathy
4.2. Global Cardiomyopathy Market, By Diagnosis Test
4.2.1. Chest X-Ray
4.2.2. Echocardiogram
4.2.3. Electrocardiogram (Ecg)
4.2.4. Treadmill Stress Test
4.2.5. Cardiac Catheterization
4.2.6. Cardiac Mri
4.2.7. Cardiac Ct Scan
4.2.8. Blood Tests
4.2.9. Genetic Testing Or Screening
4.3. Global Cardiomyopathy Market, By Treatment
4.3.1. Medication
4.3.2. Surgically Implanted Devices
4.3.2.1. Implantable Cardioverter-Defibrillator (Icd)
4.3.2.2. Ventricular Assist Device (Vad)
4.3.2.3. Pacemaker
4.3.3. Nonsurgical Procedures
4.3.3.1. Septal Ablation
4.3.3.2. Radiofrequency Ablation
4.3.4. Surgery
4.3.4.1. Septal Myectomy
4.3.4.2. Heart Transplant
4.4. Global Cardiomyopathy Market, By End User
4.4.1. Homecare
4.4.2. Hospitals And Clinics
4.4.3. Diagnostic Center
4.4.4. Other

Chapter 5. Competitive Landscape
5.1. Key Company Analysis
5.2. Key Strategic Analysis

Chapter 6. Regional Analysis
6.1. North American
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. U.K
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Roe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Roapac
6.4. Rest Of The World

Chapter 7. Company Profiles
7.1. Abbott Diagnostics
7.2. Array Biopharma, Inc.
7.3. Astrazeneca Plc
7.4. Becton And Dickson & Co.
7.5. Bg Medicine Inc.
7.6. Biomerieux
7.7. Bio-Rad Laboratories
7.8. Boston Scientific Corporation
7.9. Bristol-Myers Squibb
7.10. Cisbio Bioassays
7.11. Covance
7.12. Critical Diagnostics
7.13. Glaxosmithkline Plc
7.14. Ionis Pharmaceuticals
7.15. Janssen Pharmaceuticals, Inc.
7.16. Medtronic
7.17. Merck & Co., Inc.
7.18. Mylan N.V.
7.19. Novartis International Ag
7.20. Pfizer, Inc.
7.21. Randox Laboratories Ltd.
7.22. Response Biomedical Corporation
7.23. F. Hoffmann-La Roche Ltd
7.24. Sanofi S.A.
7.25. Siemens Healthcare
7.26. Takeda Pharmaceutical Company Ltd
7.27. Teva Pharmaceutical Industries Ltd.
7.28. Thermo Fisher Scientific Inc.
7.29. Vericel Corporation

List Of Tables
Table # 1 Global Cardiomyopathy Market Research And Analysis By Type, 2017-2023 ($ Million)
Table # 2 Global Dilated Cardiomyopathy Market Research And Analysis, 2017-2023 ($ Million)
Table # 3 Hypertrophic Cardiomyopathy Market Research And Analysis, 2017-2023 ($ Million)
Table # 4 Restrictive Cardiomyopathy Market Research And Analysis, 2017-2023 ($ Million)
Table # 5 Arrhythmogenic Right Ventricular Dysplasia Market Research And Analysis, 2017-2023 ($ Million)
Table # 6 Unclassified Cardiomyopathy Market Research And Analysis, 2017-2023 ($ Million)
Table # 7 Global Cardiomyopathy Market Research And Analysis By Diagnosis Test, 2017-2023 ($ Million)
Table # 8 Global Chest X-Ray Market Research And Analysis, 2017-2023 ($ Million)
Table # 9 Global Echocardiogram Market Research And Analysis, 2017-2023 ($ Million)
Table # 10 Global Electrocardiogram (Ecg) Market Research And Analysis, 2017-2023 ($ Million)
Table # 11 Global Treadmill Stress Test Market Research And Analysis, 2017-2023 ($ Million)
Table # 12 Global Cardiac Catheterization Market Research And Analysis, 2017-2023 ($ Million)
Table # 13 Global Cardiac Mri Market Research And Analysis, 2017-2023 ($ Million)
Table # 14 Global Cardiac Ct Scan Market Research And Analysis, 2017-2023 ($ Million)
Table # 15 Global Blood Tests Market Research And Analysis, 2017-2023 ($ Million)
Table # 16 Global Genetic Testing Or Screening Market Research And Analysis, 2017-2023 ($ Million)
Table # 17 Global Cardiomyopathy Market Research And Analysis By Treatment, 2017-2023 ($ Million)
Table # 18 Global Medication Market Research And Analysis, 2017-2023 ($ Million)
Table # 19 Global Surgically Implanted Devices Market Research And Analysis, 2017-2023 ($ Million)
Table # 20 Global Nonsurgical Procedure Market Research And Analysis, 2017-2023 ($ Million)
Table # 21 Global Surgery Market Research And Analysis, 2017-2023 ($ Million)
Table # 22 Global Cardiomyopathy Market Research And Analysis By End User, 2017-2023 ($ Million)
Table # 23 Global Hospitals And Clinics Market Research And Analysis, 2017-2023 ($ Million)
Table # 24 Global Homecare Market Research And Analysis, 2017-2023 ($ Million)
Table # 25 Global Diagnosis Center Market Research And Analysis, 2017-2023 ($ Million)
Table # 26 Global Other End User Market Research And Analysis, 2017-2023 ($ Million)
Table # 27 Global Cardiomyopathy Market Research And Analysis By Geography, 2017-2023 ($ Million)
Table # 28 North American Cardiomyopathy Market Research And Analysis By Country, 2017-2023 ($ Million)
Table # 29 North American Cardiomyopathy Market Research And Analysis By Type, 2017-2023 ($ Million)
Table # 30 North American Cardiomyopathy Market Research And Analysis By Diagnostic Test, 2017-2023 ($ Million)
Table # 31 North American Cardiomyopathy Market Research And Analysis By Treatment, 2017-2023 ($ Million)
Table # 32 North American Cardiomyopathy Market Research And Analysis By End User, 2017-2023 ($ Million)
Table # 33 European Cardiomyopathy Market Research And Analysis By Country, 2017-2023 ($ Million)
Table # 34 European Cardiomyopathy Market Research And Analysis By Type, 2017-2023 ($ Million)
Table # 35 European Cardiomyopathy Market Research And Analysis By Diagnostic Test, 2017-2023 ($ Million)
Table # 36 European Cardiomyopathy Market Research And Analysis By Treatment, 2017-2023 ($ Million)
Table # 37 European Cardiomyopathy Market Research And Analysis By End User, 2017-2023 ($ Million)
Table # 38 Apac Cardiomyopathy Market Research And Analysis By Country, 2017-2023 ($ Million)
Table # 39 Apac Cardiomyopathy Market Research And Analysis By Type, 2017-2023 ($ Million)
Table # 40 Apac Cardiomyopathy Market Research And Analysis By Diagnostic Test, 2017-2023 ($ Million)
Table # 41 Apac Cardiomyopathy Market Research And Analysis By Treatment, 2017-2023 ($ Million)
Table # 42 Apac Cardiomyopathy Market Research And Analysis By End User, 2017-2023 ($ Million)
Table # 43 Row Cardiomyopathy Market Research And Analysis By Type, 2017-2023 ($ Million)
Table # 44 Row Cardiomyopathy Market Research And Analysis By Diagnostic Test, 2017-2023 ($ Million)
Table # 45 Row Cardiomyopathy Market Research And Analysis By Treatment, 2017-2023 ($ Million)
Table # 46 Row Cardiomyopathy Market Research And Analysis By End User, 2017-2023 ($ Million)

List Of Figures
Figure # 1 Global Cardiomyopathy Market Share By Type, 2017 Vs 2023 (%)
Figure # 2 Global Cardiomyopathy Market Share By Diagnostic Test, 2017 Vs 2023 (%)
Figure # 3 Global Cardiomyopathy Market Share By Treatment, 2017 Vs 2023 (%)
Figure # 4 Global Cardiomyopathy Market Share By End User, 2017 Vs 2023 (%)
Figure # 5 Us Cardiomyopathy Market Size, 2017-2023 ($ Million)
Figure # 6 Canada Cardiomyopathy Market Size, 2017-2023 ($ Million)
Figure # 7 Uk Cardiomyopathy Market Size, 2017-2023 ($ Million)
Figure # 8 France Cardiomyopathy Market Size, 2017-2023 ($ Million)
Figure # 9 Germany Cardiomyopathy Market Size, 2017-2023 ($ Million)
Figure # 10 Italy Cardiomyopathy Market Size, 2017-2023 ($ Million)
Figure # 11 Spain Cardiomyopathy Market Size, 2017-2023 ($ Million)
Figure # 12 Roe Cardiomyopathy Market Size, 2017-2023 ($ Million)
Figure # 13 India Cardiomyopathy Market Size, 2017-2023 ($ Million)
Figure # 14 China Cardiomyopathy Market Size, 2017-2023 ($ Million)
Figure # 15 Japan Cardiomyopathy Market Size, 2017-2023 ($ Million)
Figure # 16 Roapac Cardiomyopathy Market Size, 2017-2023 ($ Million)
Figure # 17 Rest Of The World Cardiomyopathy Market Size, 2017-2023 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Diagnostics
  • Array Biopharma, Inc.
  • Astrazeneca Plc
  • Becton And Dickson & Co.
  • Bg Medicine Inc.
  • Biomerieux
  • Bio-Rad Laboratories
  • Boston Scientific Corporation
  • Bristol-Myers Squibb
  • Cisbio Bioassays
  • Covance
  • Critical Diagnostics
  • Glaxosmithkline Plc
  • Ionis Pharmaceuticals
  • Janssen Pharmaceuticals, Inc.
  • Medtronic
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis International Ag
  • Pfizer, Inc.
  • Randox Laboratories Ltd.
  • Response Biomedical Corporation
  • F. Hoffmann-La Roche Ltd
  • Sanofi S.A.
  • Siemens Healthcare
  • Takeda Pharmaceutical Company Ltd
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • Vericel Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll